HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcome of infants born to hepatitis C infected women.

AbstractBACKGROUND:
Hepatitis C virus (HCV) can be transmitted vertically from mother to infant, either late in pregnancy or at delivery.
AIMS:
To determine the outcome of infants born to HCV infected women, to characterise epidemiology and to design an appropriate infant monitoring schedule.
METHODS:
Three hundred and fourteen infants, born to 296 HCV positive women between 1994 and 1999 were monitored for a median of 18 months (range 1-52).
RESULTS:
Forty per cent of infants were small for age and 46% had neonatal abstinence syndrome (NAS). Of 173 infants of defined status, 11 were infected (vertical transmission rate [VTR] 6.4%, 95% CI 2.8-10). Infected infants were diagnosed at a median of three months (range 0.5-10). Liver transaminases elevation was documented in 8% of uninfected infants. A negative HCV PCR test before one month of age did not exclude infection but all infected patients had detectable HCV RNA when next tested (range 2-10 months).
CONCLUSIONS:
94% of infants born to HCV antibody positive women are not HIV infected. Liver transaminase elevation in exposed infants is not always indicative of infection. A minimum monitoring schedule of testing (PCR and antibody) at six to eight weeks, six and 18 months allows early diagnosis while detecting late seroconversions.
AuthorsC M Healy, M T Cafferkey, A Conroy, S Dooley, W W Hall, M Beckett, T A Clarke, M J White, W A Gorman, K M Butler
JournalIrish journal of medical science (Ir J Med Sci) 2001 Apr-Jun Vol. 170 Issue 2 Pg. 103-6; discussion 92-3 ISSN: 0021-1265 [Print] Ireland
PMID11491043 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Chi-Square Distribution
  • Delivery, Obstetric
  • Female
  • Follow-Up Studies
  • Hepatitis C (diagnosis, epidemiology, transmission)
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical
  • Male
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: